NEW YORK, April 20, 2018 /PRNewswire/ -- DFB Healthcare
Acquisitions Corp. (NASDAQ: DFBHU) ("DFB Healthcare") announced
today that the holders of its units may elect to separately trade
the common stock and warrants underlying the units commencing on
April 16, 2018. No fractional
warrants will be issued upon separation of the units and only whole
warrants will trade. Those units that are not separated will
continue to trade on the NASDAQ Capital Market under the symbol
"DFBHU" and the common stock and warrants are expected to trade
under the symbols "DFBH" and "DFBHW," respectively.
The units were initially offered by DFB Healthcare in an
underwritten offering. Goldman Sachs & Co. and Deutsche Bank
Securities acted as joint book runners for the offering and Leerink
Partners acted as co-manager.
A registration statement relating to the units and the
underlying securities was declared effective by the Securities and
Exchange Commission (the "SEC") on July 27,
2017.
A registration statement relating to these securities has been
filed with, and declared effective by, the SEC on February 15, 2018. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. The registration
statement can be obtained at www.sec.gov.
The offering was made only by means of a prospectus, copies of
which may be obtained from Goldman, Sachs & Co., Attention:
Prospectus Department, 200 West Street, New York, NY 10282, or by telephone toll-free
at 1-866-471-2526 or by email at prospectus-ny@ny.email.gs.com,
from Deutsche Bank Securities Inc., Attention: Prospectus Group, 60
Wall Street, New York, New York
10005-2836 (Tel: (800) 503-4611; Email: prospectus.CPDG@db.com),
and from Leerink Partners LLC, Attention: Syndicate Department, One
Federal Street, 37th Floor, Boston,
MA 02110, by telephone at 800-808-7525, ext. 6132 or by
email at syndicate@leerink.com.
Forward-Looking Statements:
This press release includes forward-looking statements that
involve risks and uncertainties. Forward-looking statements
are statements that are not historical facts. Such
forward-looking statements are subject to risks and uncertainties,
which could cause actual results to differ from the forward-looking
statements. Information concerning risks and uncertainties can
be found in DFB Healthcare's filings with the SEC, including those
set forth in the Risk Factors section of DFB Healthcare's
prospectus. DFB Healthcare expressly disclaims any obligations or
undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change
in DFB Healthcare's expectations with respect thereto or any change
in events, conditions or circumstances on which any statement is
based.
Contact:
DFB Healthcare Acquisitions Corp.
Chris Wolfe, (212) 965-2400
chris.wolfe@dfbhealthcare.com
View original
content:http://www.prnewswire.com/news-releases/dfb-healthcare-acquisitions-corp-common-stock-and-warrants-to-commence-trading-separately-on-april-20-2018-300633865.html
SOURCE DFB Healthcare Acquisitions Corp.
